EDGAR·FLOW

REGENERON PHARMACEUTICALS, INC. — Form 4

Filed November 18, 2026 · analyzed by the Insider Agent
4 ▼ Likely negative significance 59/100
What the filing says
Co-Chief Scientific Officer MURPHY ANDREW J (REGN) sold 34K shares (~$16.3M) on the open market (42% of holdings). Large sale — ~42% of holdings.
Why this rating

Large sale — ~42% of holdings.

View original filing on SEC.gov ↗ REGN · stock on Yahoo Finance ↗

See more from November 18, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.